THIS SITE IS INTENDED FOR U.S. HEALTHCARE PROFESSIONALS ONLY.

device rotation icon

This website is best viewed using the horizontal display on your tablet device.

device rotation icon

This website is best viewed using the vertical display on your mobile device.

THIS SITE IS INTENDED FOR U.S HEALTHCARE PROFESSIONALS ONLY.

Request Medical Information

HEALTHCARE PROFESSIONAL RESOURCES

MPACT Study Videos

Dr. George Kim reviews the MPACT study—the largest multinational Phase III study in metastatic pancreatic cancer (mPC) using ABRAXANE + gemcitabine in the first-line setting.

MPACT Study Design

Dr. Kim presents the study design and results in the MPACT study.

MPACT Efficacy

Dr. Kim presents the efficacy results for ABRAXANE in the MPACT study (including OS, ORR, and PFS).

MPACT Safety

Dr. Kim presents the safety results for ABRAXANE in the MPACT study.

MPACT Dosing

Dr. Kim presents dosing and schedule recommendations for ABRAXANE in the MPACT study.

ABRAXANE Reconstitution Video

This video will guide you through the appropriate process of reconstituting ABRAXANE.

Knowledge Is Power in Treating mPC

Discover why Philip Agop Philip, MD, professor of oncology and pharmacology at the Karmanos Cancer Center, believes doctors staying up-to-date on the standard of care is essential to ensuring mPC patients receive the most appropriate treatments.

NEJM Clinical Reprint

Results from the Phase III Study: ABRAXANE plus gemcitabine for mPC.

mPC Dosing Card

Dosing Instructions for ABRAXANE mPC indication, including starting dose/schedule and dose modifications for certain treatment-related adverse reactions.

mPC NCCN Flashcard

This useful flashcard summarizes the NCCN Category 1 recommendation for first-line ABRAXANE + gemcitabine for mPC patients with KPS 70-100.

ABRAXANE Full Prescribing Information

Download the Prescribing Information for ABRAXANE.

ABRAXANE is indicated for the first-line treatment of patients with metastatic adenocarcinoma of the pancreas, in combination with gemcitabine.

CLOSE THE TAB

ABRAXANE Reconstitution Video

This video will guide you through the appropriate process of reconstituting ABRAXANE.

ABRAXANE Full Prescribing Information

Download the Prescribing Information for ABRAXANE.

ABRAXANE is indicated for the treatment of breast cancer after failure of combination chemotherapy for metastatic disease or relapse within 6 months of adjuvant chemotherapy. Prior therapy should have included an anthracycline unless clinically contraindicated.

CLOSE THE TAB

ABRAXANE Reconstitution Video

This video will guide you through the appropriate process of reconstituting ABRAXANE.

ABRAXANE Full Prescribing Information

Download the Prescribing Information for ABRAXANE.

ABRAXANE is indicated for the first-line treatment of locally advanced or metastatic non–small cell lung cancer, in combination with carboplatin, in patients who are not candidates for curative surgery or radiation therapy.

CLOSE THE TAB

RESOURCE FOR YOUR PATIENTS

Patient Brochure for Metastatic Pancreatic, Breast, and Lung Cancer

Preparing for My Treatment

Preparing for My Treatment

Shows your patients items they may want to have on hand and arrangements they might want to make before their treatment begins. Also provides guidance on information they should share with you and a list of frequently asked questions about treatment with ABRAXANE.

References: 1. Paclitaxel. Package insert. Hospira, Inc; 2018. 2. Taxotere. Package insert. Sanofi-Aventis U.S. LLC; 2020.